Filing Details
- Accession Number:
- 0001127602-20-005720
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-14 17:11:37
- Reporting Period:
- 2020-02-12
- Accepted Time:
- 2020-02-14 17:11:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1537208 | D Sandra Vaart Der Van | 531 South Spring Street Burlington NC 27215 | Svp, Global General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-12 | 290 | $0.00 | 2,819 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-12 | 80 | $187.51 | 2,739 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2020-02-12 | 283 | $0.00 | 3,022 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-12 | 78 | $187.51 | 2,944 | No | 4 | F | Direct | |
Common Stock | Disposition | 2020-02-13 | 105 | $188.49 | 2,839 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-02-13 | 103 | $188.49 | 2,736 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Unit | Disposition | 2020-02-12 | 290 | $0.00 | 290 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2020-02-12 | 283 | $0.00 | 283 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,040 | No | 4 | M | Direct | ||
1,757 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- Stock withholding to satisfy tax withholding obligations.
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2019.
- This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020.